Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target.

ABSTRACT:

SUBMITTER: Hosoya K 

PROVIDER: S-EPMC11002497 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature